| Dr Kamlesh Natvarlal Patel, MD | |
|
2424a Warm Springs Rd, Columbus, GA 31904-5638 | |
| (706) 327-6296 | |
| (706) 571-0036 |
| Full Name | Dr Kamlesh Natvarlal Patel |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 37 Years |
| Location | 2424a Warm Springs Rd, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902897788 | NPI | - | NPPES |
| 000078712 | Medicaid | AL | |
| 390006224 | Other | RAILROAD MEDICARE | |
| 000795517L | Medicaid | GA | |
| 52598033 | Other | UNITED HEALTHCARE | |
| 598034 | Other | GA | BC/BS |
| 51078712 | Other | AL | BC/BS |
| 000795517D | Medicaid | GA | |
| 305007 | Other | WELLCARE MEDICAID | |
| 000795517E | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 045576 (Georgia) | Primary |
| 207RN0300X | Internal Medicine - Nephrology | 21755 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dci Boxwood Place | Columbus, GA | Dialysis facility |
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Piedmont Columbus Regional Northside | Columbus, GA | Hospital |
| Jack Hughston Memorial Hospital | Phenix city, AL | Hospital |
| Warm Springs Medical Center | Warm springs, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Columbus, P.c. | 0244221968 | 4 |
| Nephrology Associates Of Columbus, P.c. | 0244221968 | 4 |
News Archive
Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.
A team of researchers, co-led by a University of California, Riverside professor, has found a long-sought-after mechanism in human cells that creates immunity to influenza A virus, which causes annual seasonal epidemics and occasional pandemics.
Lineagen announces the launch of its FirstStep integrated genetic testing and counseling service to assist pediatricians and family physicians with the earlier, more accurate diagnostic evaluation of autism spectrum disorders and developmental delay.
› Verified 8 days ago
| Entity Name | Nephrology Associates Of Columbus, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689767295 PECOS PAC ID: 0244221968 Enrollment ID: O20051227000499 |
News Archive
Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.
A team of researchers, co-led by a University of California, Riverside professor, has found a long-sought-after mechanism in human cells that creates immunity to influenza A virus, which causes annual seasonal epidemics and occasional pandemics.
Lineagen announces the launch of its FirstStep integrated genetic testing and counseling service to assist pediatricians and family physicians with the earlier, more accurate diagnostic evaluation of autism spectrum disorders and developmental delay.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kamlesh Natvarlal Patel, MD 2424a Warm Springs Rd, Columbus, GA 31904-5638 Ph: (706) 327-6296 | Dr Kamlesh Natvarlal Patel, MD 2424a Warm Springs Rd, Columbus, GA 31904-5638 Ph: (706) 327-6296 |
News Archive
Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
Shahriar Koochekpour, MD, PhD, Assistant Professor of Microbiology and Immunology, Biochemistry and Molecular Biology, and Genetics at LSU Health Sciences Center New Orleans, led research that has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease.
A team of researchers, co-led by a University of California, Riverside professor, has found a long-sought-after mechanism in human cells that creates immunity to influenza A virus, which causes annual seasonal epidemics and occasional pandemics.
Lineagen announces the launch of its FirstStep integrated genetic testing and counseling service to assist pediatricians and family physicians with the earlier, more accurate diagnostic evaluation of autism spectrum disorders and developmental delay.
› Verified 8 days ago
Andrew N Vernon, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expy, Columbus, GA 31904 Phone: 706-320-2773 Fax: 706-596-4226 | |
Dr. Christopher Morgan Lee, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 700 Center St, Suite 204, Columbus, GA 31901 Phone: 706-596-1314 Fax: 706-596-9225 | |
Dr. James Lacey Smith, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1207 Marina Cove Dr, Columbus, GA 31904 Phone: 901-412-1881 | |
Srividya Srinivasamaharaj, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1831 5th Ave, Columbus, GA 31904 Phone: 706-320-8780 Fax: 706-320-8721 | |
Dr. Mylena E Morton, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1262 Fax: 706-660-6512 | |
Da Monica Alethea Cannon, NP Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2737 Warm Springs Rd Ste C, Columbus, GA 31904 Phone: 706-571-1136 | |
Dr. Gregory Michael Rucker, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 700 Center St, Suite 204, Columbus, GA 31901 Phone: 706-596-1314 Fax: 706-596-9225 |